17Jul 2024
Systemic and ocular outcomes in TB-immunoreactive patients receiving immunomodulatory therapy

Systemic and ocular outcomes in TB-immunoreactive patients receiving immunomodulatory therapy

This study compared systemic and ocular outcomes in patients with non-infectious uveitis who had TB-immunoreactivity and received immunomodulatory therapy (IMT). Results indicated a low risk of TB reactivation and no additional adverse ocular effects in TB-immunoreactive patients.

  • #ophthalmology

Like

Save

Share